Diffuse co-expression of TTF-1 and p40 (ΔNp63) defines a distinct biphenotypic non-small cell lung carcinoma: clinicopathologic and molecular characterization of 19 cases弥漫性共表达TTF-1和p40 (ΔNp63)定义了一种独特的双表型非小细胞肺癌:19例的临床病理及分子特征Diagnostic PathologyIF2.32026-03-010PRE
Human leukocyte antigen class II-based immune risk model for recurrence evaluation in stage I-III small cell lung cancerJOURNAL FOR IMMUNOTHERAPY OF CANCERIF10.62021-08-0615OAAI
FOXP3-based immune risk model for recurrence prediction in small-cell lung cancer at stages I-IIIJOURNAL FOR IMMUNOTHERAPY OF CANCERIF10.62021-05-1823OAAI
Comprehensive genomic profiling of combined small cell lung cancer联合小细胞肺癌的综合基因组分析TRANSLATIONAL LUNG CANCER RESEARCHIF3.52021-02-0114OAAI
Galectin-9-based immune risk score model helps to predict relapse in stage I-III small cell lung cancerJOURNAL FOR IMMUNOTHERAPY OF CANCERIF10.62020-10-2026OAAI
Procedure-specific prognostic impact of micropapillary subtype may guide resection strategy in small-sized lung adenocarcinomas: a multicenter studyTHERAPEUTIC ADVANCES IN MEDICAL ONCOLOGYIF4.22020-07-0334OAAI
Detecting Ultralow Frequency Mutation in Circulating Cell-Free DNA of Early-Stage Nonsmall Cell Lung Cancer Patients with Unique Molecular Identifiers用独特分子标识符检测早期非小细胞肺癌患者循环游离DNA超低频率突变SMALL METHODSIF9.12019-04-2612PREAI